All News

New 4-year data from the ADlong trial show lebrikizumab achieved EASI-75 in 94% of atopic dermatitis patients on once-monthly maintenance dosing.

Episode highlights include a new AD blood test for PCPs, sleep effects of elinzanetant among postmenopausal women, lung cancer screening gains, and more.

Your daily dose of the clinical news you may have missed.

COVID-19 infection increased risks of AKI, CKD, and ESRD vs influenza in a 3 million–patient US study, highlighting need for kidney monitoring.

New data to be presented at ACC 2026 shows 6 hours of daily screen time may lead to higher BP, LDL-C, BMI, and nicotine use, independent of exercise.

Your daily dose of the clinical news you may have missed.

Dr Bhatt emphasizes that clinical targets for biological variables like blood pressure and LDL-C are crucial for effective patient care.

Replacing 30 minutes of sedentary time with sleep or exercise was linked to lower insulin resistance in teens in preliminary AHA EPI 2026 data.

Test your knowledge of added sugar limits, processed food reduction, and label interpretation in the 2025–2030 Dietary Guidelines.

Linda Stein Gold, MD, discusses recognizing when psoriasis patients need systemic therapy, and how icotrokinra's once-daily oral dosing can change the conversation.

Expert discussion on how updated guidelines

FDA clears MiniMed Flex insulin pump with smartphone control and adaptive algorithm for type 1 and insulin-requiring type 2 diabetes.

Gerontological GSA and AAFP explain digital cognitive tests for Alzheimer/dementia, EHR-ready, repeatable, supports KAER care in primary care.

FDA clears once-daily icotrokinra pill for moderate-to-severe plaque psoriasis, with strong PASI responses and placebo-like safety.

AHA-style dyslipidemia update from Johns Hopkins: test Lp(a) once, then target LDL-C goals to cut cardiovascular risk and cholesterol.

Expert discussion on how updated guidelines intersect with state vaccination requirements for school entry.

Prescriptions data shows one antibiotic course reshapes gut microbiome for years, depleting Bacillota and guiding smarter prescribing.

Test your knowledge of saturated fat thresholds, sodium limits, and alcohol recommendations in the 2025–2030 Dietary Guidelines.